WWL229

WWL229 Suppliers list
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: BOC Sciences  
Tel: 16314854226
Email: info@bocsci.com
Company Name: Pharmacodia (Beijing) Co.,Ltd  
Tel: +86-400-851-9921
Email: sales@pharmacodia.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Amadis Chemical Company Limited  
Tel: 571-89925085
Email: sales@amadischem.com

WWL229 manufacturers

  • WWL229
  • WWL229 pictures
  • $42.00
  • 2026-07-28
  • CAS:1338575-28-2
  • Purity: 98.15%
  • Supply Ability: 10g
WWL229 Basic information
Product Name:WWL229
Synonyms:WWL229;XVBRVSAGMWRVCK-UHFFFAOYSA-N;Reaxys ID: 25732135;1-Piperidinecarboxylic acid, 2-(3-methoxypropyl)-, 4-nitrophenyl ester;WWL229 4-Nitrophenyl 2-(3-methoxypropyl) piperidine-1-carboxylate;WWL 229,WWL-229,Inhibitor,inhibit,WWL229;WWL229, 10 mM in DMSO;4-nitrophenyl 2-(3-methoxypropyl) piperidine-1-carboxylate
CAS:1338575-28-2
MF:C16H22N2O5
MW:322.36
EINECS:
Product Categories:
Mol File:1338575-28-2.mol
WWL229 Structure
WWL229 Chemical Properties
storage temp. 2-8°C
solubility DMF: 30 mg/ml; DMSO: 25 mg/ml; Ethanol: 30 mg/ml; Ethanol:PBS(pH 7.2) (1:1): 0.5 mg/ml
form oil
color colorless to light yellow
InChI1S/C16H22N2O5/c1-22-12-4-6-13-5-2-3-11-17(13)16(19)23-15-9-7-14(8-10-15)18(20)21/h7-10,13H,2-6,11-12H2,1H3
InChIKeyXVBRVSAGMWRVCK-UHFFFAOYSA-N
SMILESO=C(OC1=CC=C([N+]([O-])=O)C=C1)N2C(CCCOC)CCCC2
Safety Information
WGK Germany WGK 3
Storage Class11 - Combustible Solids
MSDS Information
WWL229 Usage And Synthesis
UsesWWL229 is a selective inhibitor of Ces3 (carboxylesterase-3) which mediates triglyceride hydrolysis in white adipose tissue. Potential anti-diabetic agent.
Biological ActivityWWL229 is a highly selective inhibitor of mouse Carboxylesterase 3 (Ces3) and human CES1 (orthologue of mCes3), serine hydrolases involved in lipolysis in addition to their activities as liver detoxification enzymes. WWL229 inhibits mCes3 with an IC50 of 10 μM, but not Ces1f, ABHD6 or other tested serine hydrolases. In a recent study, hCES1 activity was found to be increased two-fold in obese individuals and patients with type 2 diabetes compared to lean subjects, and is thought to generate surplus fatty acids th at can deposit ectopically in tissues. WWL229 inhibits adipocyte basal lipolysis and promotes differentiation and lipid storage in adipocytes.
WWL229 Preparation Products And Raw materials
Tag:WWL229(1338575-28-2) Related Product Information
WY-14643 Wnt-C59 Wnt Agonist WS3 WWL123 WWL113 WWL70 4-[2-(cyclopropanecarbonylamino)-[1,2,4]triazolo[1,5-a]pyridin-5-yl]benzoic acid WWL 154